|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes. a review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: analysis of the returned device identified weight within specifications, crease fold, deformation, yellow particles.A microscopic analysis was performed which identified no other observation.Based on the device analysis the final assessment is: no issues found related with the manufacturing process.The events of pain and seroma are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: pain, swelling, and seroma.
|